Dr. Fazlul-Hoque Chowdhury is a seasoned executive and innovator with over two decades of leadership in the life sciences industry. His extensive expertise spans pharmaceuticals, vaccines, and diagnostic platforms, driving innovation from concept to commercial reality. As the former Chairman and CEO of a Nasdaq-listed company for over a decade, Dr. Chowdhury possesses a proven track record of steering organizations through complex regulatory landscapes and achieving significant growth. A prolific inventor, he holds over 100 patents across multiple pioneering technology platforms, underscoring his commitment to advancing medical science. His thought leadership is further demonstrated through authoring textbook chapters for esteemed scientific publishers. A adept strategist and fundraiser, Dr. Chowdhury has successfully secured over $85 million in funding to fuel various high-impact ventures. He is now focused on leveraging this wealth of experience to revolutionize vaccine delivery and address critical global health challenges.